MagicMushroomsDirectory
Research

Usona Institute

Clinical Trial in Madison, Wisconsin

Usona Institute is developing psilocybin as a potential treatment for major depressive disorder. Its official psilocybin page describes the uAspire Phase 3 study, and ClinicalTrials.gov lists NCT06308653 with Usona Institute as lead sponsor.

ResearchClinical Trial
Visit Website
Usona Institute

What They List

  • Psilocybin Research
  • Clinical Trials
  • Major Depression Study

Directory Facts

Status
Research Institution
Price
Not published
Hours
Verify with provider
License / Record
Not listed
Last Verified
2026-06-12

Location

Madison, WI

Source Notes

NCT06308653 is active-not-recruiting as of ClinicalTrials.gov check.

Source: https://www.usonainstitute.org/psilocybin; https://clinicaltrials.gov/study/NCT06308653

Official Photos

Images sourced from the listing's public website or public source profile.

Official site image from Usona Institute showing research, campus, center, or program context.
Official site image from Usona Institute showing research, campus, center, or program context.
Official site image from Usona Institute showing research, campus, center, or program context.
Official site image from Usona Institute showing research, campus, center, or program context.
Informational listing only.

MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.